Prestige Consumer Healthcare Inc (PBH) Return on Investment ROI from the first quarter of 2026 to first quarter of 2026 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Prestige Consumer Healthcare Inc   (NYSE: PBH)


Prestige Consumer Healthcare Inc's ROI from its first quarter of 2026 to the first quarter of 2026 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Prestige Consumer Healthcare Inc's ROI in the first quarter of 2026?
Prestige Consumer Healthcare Inc achieved a return on average invested assets (ROI) of 11.29 % in its first quarter of 2026, this is above PBH's average return on investment of 6.24%.
Prestige Consumer Healthcare Inc s investments during the 12 months ending in the first quarter of 2026 are valued at $3 billion

ROI decreased relative to the period ending Mar 31 2026, due to the decline in net income.

Within the Healthcare sector 67 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the fourth quarter of 2026 from 567 to 662.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2026)
I. Quarter		 (Mar 31 2026)
IV. Quarter		 (Dec 31 2025)
III. Quarter		 (Sep 30 2025)
II. Quarter		 (Jun 30 2025)
I. Quarter
Y / Y Investment Change TTM 10.46 % 3.09 % 3.24 % 2.57 % 1.86 %
Y / Y Net Income Change TTM -18.84 % -10.22 % 20.94 % 108.06 % 365.72 %
Investment (TTM) in Millions 4,415 3,373 3,296 3,308 3,322
Return On Investment (TTM) 11.29 % 13.47 % 13.71 % 14.81 % 15.37 %
PBH's Overall Ranking # 662 # 567 # 192 # 563 # 396
Seq. Investment Change TTM 8.22 % 0.59 % 0.72 % 0.75 % 1 %
Seq. Net Income Change TTM -9.27 % -1.19 % -6.73 % -2.94 % 0.35 %
Net Income (TTM) in Millions 406 448 453 486 501

PBH Company Profile >> Back to PBH Roi Comparisons >> See Annual PBH Return On Investment



Return On Investment PBH's Ranking
Within: No.
Industry # 19
Sector # 68
Overall # 662

Return On Investment Statistics
High Average Low
13.71 %
6.24 %
-2.28 %
(Mar 31 2025)   (Jun 30 2023)







Financial Statements
Prestige Consumer Healthcare Inc's I. Quarter Investments $ 4,415 Millions PBH's Balance sheet
Prestige Consumer Healthcare Inc's I. Quarter Income $ 68 Millions Quarterly PBH's Income Statement
PBH's Income by Division See PBH's Income by Division


PBH Annual Return On Investment (Mar 31 2026)
2026		 (Mar 31 2025)
2025		 (Mar 31 2024)
2024		 (Mar 31 2023)
2023		 (Mar 31 2022)
2022
Total Investments in Millions 3,373 3,296 3,201 3,193 3,527
Y / Y Investment Growth 2.36 % 2.94 % 0.26 % -9.48 % 6.66 %
Net Income in Millions 448 499 485 -82 205
Y / Y Net Income Growth -10.22 % 2.77 % - - 24.71 %
Annual Return On Investment 13.27 % 15.14 % 15.16 % -2.58 % 5.82 %


Annual Roi Comment
In the fiscal year 2026 ROI decreased relative to the previous year to 13.27 %, due to deterioration of net income.

Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
PBH's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for PBH's Competitors
Subscribers only: Roi for Prestige Consumer Healthcare Inc's Suppliers
Subscribers only: Return On Investment for PBH's Customers

Other Ratios
PBH's Roa PBH's Inventory Turnover Ratio PBH's Growth Rates PBH's Dividend Statistics
PBH's Profitability Ratios PBH's Asset Turnover Ratio PBH's Dividend Growth
PBH's Roe PBH's Valuation Ratios PBH's Financial Strength Ratios PBH's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI
Caredx Inc   29.42 %
Adma Biologics Inc   28.94 %
Protalix Biotherapeutics inc   25.72 %
Pro dex Inc   24.29 %
Innoviva Inc   23.33 %
Electromed Inc   23.18 %
Zevra Therapeutics Inc   22.90 %
Iradimed Corporation  22.57 %
Alnylam Pharmaceuticals Inc   22.10 %
Eton Pharmaceuticals Inc   21.31 %
Dexcom Inc   20.98 %
Healthcare Services Group Inc   20.93 %
Arcutis Biotherapeutics Inc   20.77 %
Chemed Corporation  20.13 %
Resmed Inc   20.01 %
Halozyme Therapeutics Inc   19.99 %
Vertex Pharmaceuticals Inc  19.97 %
Agilent Technologies inc   19.84 %
Illumina Inc   19.61 %
Puma Biotechnology Inc   19.60 %
United Therapeutics Corporation  19.53 %
Zoetis Inc   19.44 %
Krystal Biotech Inc   19.16 %
Carlisle Companies Incorporated  18.88 %
Neurocrine Biosciences Inc   17.51 %
Intuitive Surgical Inc   17.11 %
Theravance Biopharma inc   17.10 %
Standard Biotools Inc   16.38 %
Inspire Medical Systems inc   16.34 %
Aveanna Healthcare Holdings Inc   16.32 %

Date modified: 2026-09-26T06:52:03+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.